Streetbeat News

Products Services

IYE

XLE

XOM

Exxon Mobil plans to sell $1 billion worth of conventional oil assets in the Permian Basin to focus on shale production after acquiring Pioneer Natural Resources. The company aims to produce 4.3 million barrels of oil and gas daily this year. Investors can gain exposure to Exxon Mobil through ETFs like XLE and IYE.

Portfolio Pulse from Lekha Gupta

August 28, 2024 | 10:43 am

SWTX

SpringWorks' Mirdametinib has received validation from the European Medicines Agency for treating NF1-PN in adults and children. The FDA has granted multiple designations, including Orphan Drug and Fast Track, indicating strong regulatory support.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 10:35 am

SWTX

SpringWorks Therapeutics announced that the FDA has accepted its New Drug Application for Mirdametinib, a treatment for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas, and granted it Priority Review with a PDUFA date set for February 28, 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 10:33 am

OCGN

Ocugen has completed dosing in the third cohort of its Phase 1/2 GARDian clinical trial for OCU410ST, a gene therapy candidate for Stargardt disease.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 10:32 am

AMZN

Amazon India plans to launch a quick commerce service in 2025, aiming to deliver products in under an hour. This move is part of a strategy to compete with local rivals like Flipkart, Zomato's Blinkit, and BigBasket's BB Now. The initiative is led by Nishant Sardana and may involve a potential stake in Swiggy's Instamart.

Portfolio Pulse from Nivedita Hazra

August 28, 2024 | 10:32 am

INFY

Infosys has announced a collaboration with the Stanford University Institute for Human-centered Artificial Intelligence to accelerate AI research initiatives.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 10:27 am

LI

Li Auto Inc reported a mixed fiscal Q2 2024 with a slight revenue miss but an EPS beat. Vehicle deliveries grew by 25.5% year-over-year, but margins declined. The company expects strong Q3 revenue and delivery growth. Despite positive developments, Li Auto's stock has faced challenges, dropping 47% over the past year.

Portfolio Pulse from Anusuya Lahiri

August 28, 2024 | 10:18 am

NVS

Novartis' Phase 3 V MONO study for Leqvio (Inclisiran) met its primary endpoints, showing effectiveness in lowering LDL cholesterol compared to placebo and ezetimibe in patients at low or moderate risk of atherosclerotic cardiovascular disease.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 10:13 am

AMZN

MSFT

Amazon has become the most popular stock among hedge funds in Q2, surpassing Microsoft. Amazon's strategic advancements in AI and its low trading multiple are key factors in its popularity.

Portfolio Pulse from Benzinga Neuro

August 28, 2024 | 10:07 am

AVGO

MSFT

NVDA

OpenAI's collaboration with Arizona State University (ASU) has resulted in 250 AI projects, integrating AI into education and research. This partnership is part of a broader trend of AI integration, with OpenAI also partnering with Condé Nast and Apple. Microsoft faces EU scrutiny over its investment in OpenAI, and OpenAI is in talks with Broadcom to develop a new AI chip.

Portfolio Pulse from Benzinga Neuro

August 28, 2024 | 9:38 am